Iambic
The Iambic AI-driven platform was created to address the most challenging design problems in drug discovery, leveraging technology innovations such as Enchant, a multi-modal transformer model that predicts clinical outcomes from the earliest stages of discovery, and NeuralPLexer, the best-in-class predictor of protein and protein-ligand structures. The integration of physics principles into the platform’s AI architectures improves data efficiency and allows molecular models to venture widely across the space of possible chemical structures. The platform enables identification of novel chemical modalities for engaging difficult-to-address biological targets, discovery of defined product profiles that optimize therapeutic window, and multi-parameter optimization for highly differentiated development candidates. Through close integration of AI-generated molecular designs with automated experimental execution, Iambic completes design-make-test cycles on a weekly cadence.
Domain
iambic.ai
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
51-100
Last Funding
$100.0M
Founded
2018
Tech Stack (9 technologies)
Frequently Asked Questions
What technologies does Iambic use?+
Iambic uses 9 technologies including Google Font API, Webflow, Webpack.
What industry is Iambic in?+
Iambic operates in the Artificial Intelligence (AI) industry.
Where is Iambic based?+
Iambic is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026